(ILARIS is registered trademarks NOVARTIS PHARMACEUTICAL CORPORATION)
What is ILARIS:
ILARIS is a medicine that contains the active substance Canakinumab and is available as 80 mg powder for solution for injection.
Generic Name: Canakinumab
Strength: 180 mg
Company: NOVARTIS PHARMACEUTICAL CORPORATION
Packing: Single Vial for Injection
Ilaris – Canakinumab 180 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.
In how many countries ILARIS is approved for marketing?
ILARIS is available/approved in USA and Europe. We can help you to access it in India.
What is ILARIS used for?
ILARIS is indicated for the treatment of:
• Cryopyrin-Associated Periodic Syndromes (CAPS), in adults and children 4 years of age and older including:
• Familial Cold Autoinflammatory Syndrome (FCAS)
• Muckle-Wells Syndrome (MWS)
• Active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 years and older
How can I get ILARIS in India?
ILARIS is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –email@example.com
We facilitate by-
• Helping in documentation to import the medicine for personal use
• Finding Genuine and reliable source in USA, Europe and Japan
• Ensuring 100% transparency.
ILARIS can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of ILARIS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees
Can I get ILARIS even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing ILARIS, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your enquiry to find –
ILARIS in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
ILARIS in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
ILARIS in North America – Mexico.
ILARIS in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
ILARIS in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
ILARIS in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
ILARIS in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
ILARIS in Australia and New Zealand.
How is ILARIS used?
ILARIS should be administered under the guidance of specialist doctor having experience in managing immunological disorders.
Recommended dose: 150 mg for CAPS patients with body weight greater than 40 kg and 2 mg/kg for CAPS patients with body weight greater than or equal to 15 kg and less than or equal to 40 kg. For children 15 to 40 kg with an inadequate response, the dose can be increased to 3 mg/kg.
If the patient develops certain serious side effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information
Are there any side-effects/ adverse reactions/precautions associated with treatment with ILARIS?
It is recommended to seek your doctor’s medical advice about side effects
How do I contact The Indian Pharma?
You can use different channel to contact The Indian Pharma (IP)
Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working days.
Email: We can also address your enquiries if sent directly to firstname.lastname@example.org. We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.
What information do you need to help patient in assisting documentation for ILARIS import for personal use?
We will require the following documents to help in documentation for Named-Patient import
- Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
- Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
- Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.